Generated by GPT-5-mini| Yasunori Ohsumi | |
|---|---|
| Name | Yasunori Ohsumi |
| Birth date | 1945-02-09 |
| Birth place | Fukuoka, Japan |
| Nationality | Japanese |
| Fields | Cell biology, Molecular biology |
| Workplaces | University of Tokyo, National Institute for Basic Biology, Tokyo Institute of Technology |
| Alma mater | University of Tokyo |
| Known for | Autophagy research |
| Awards | Nobel Prize in Physiology or Medicine, Asahi Prize, Japan Academy Prize |
Yasunori Ohsumi was a Japanese cell biologist whose experimental work elucidated fundamental mechanisms of autophagy in eukaryotic cells. His use of yeast genetics and electron microscopy established the molecular framework for autophagosome formation, linking basic science to clinical and physiological contexts addressed by institutions such as National Institutes of Health, Max Planck Society, and Howard Hughes Medical Institute. Ohsumi's findings influenced research across fields represented at conferences like the Cold Spring Harbor Laboratory meetings and informed therapeutic strategies pursued by biotechnology firms and academic centers worldwide.
Born in Fukuoka during the Shōwa period, Ohsumi completed undergraduate and graduate studies at the University of Tokyo, where he studied under mentors with ties to laboratories at Kyoto University and Osaka University. His early exposure to postwar Japanese science connected him to networks involving the Japan Society for the Promotion of Science and research groups that collaborated with researchers from Stanford University, University of Cambridge, and Harvard University. After earning his doctorate, he undertook postdoctoral training that included laboratory exchanges and techniques common in groups led by investigators from Max Planck Institute and CNRS research units.
Ohsumi established an independent laboratory at the University of Tokyo and later at the National Institute for Basic Biology, where he designed genetic and biochemical screens to probe intracellular degradation pathways. Working within the context of yeast models such as Saccharomyces cerevisiae, he adapted methods used in studies by groups affiliated with Cold Spring Harbor Laboratory and EMBL to isolate mutants defective in vacuolar functions. These efforts occurred alongside parallel inquiries by researchers at Medical Research Council units and drew conceptual links to earlier electron microscopy observations from laboratories at Rockefeller University and Yale University. Ohsumi identified a set of genes that controlled autophagy-related vesicle formation, establishing connections with proteins characterized in subsequent work at institutions like MIT, University College London, and University of California, San Francisco.
Using starvation-induced conditions in yeast cultures, Ohsumi combined genetic deletion libraries influenced by approaches at European Molecular Biology Laboratory with transmission electron microscopy strategies refined at Institute Pasteur to visualize double-membrane structures later termed autophagosomes. He performed genetic screens that isolated autophagy-defective mutants, which he cataloged as Atg genes; these discoveries resonated with biochemical pathways investigated at Johns Hopkins University and University of Pennsylvania. Key experiments demonstrated that vacuolar proteases and conjugation systems were essential for autophagosome expansion, findings that paralleled ubiquitin-like conjugation research at Max Planck Institute of Biochemistry and protein degradation studies at California Institute of Technology. Ohsumi's delineation of Atg1/ULK1 kinase complexes and Atg8/LC3 lipidation pathways provided mechanistic bridges to mammalian systems described in papers from Columbia University, Scripps Research, and University of Toronto. His work enabled other laboratories at University of Copenhagen and Seoul National University to map autophagy regulation by nutrient-sensing kinases such as TOR, integrating concepts present in studies from Weizmann Institute of Science and Imperial College London.
Ohsumi received numerous honors reflecting international recognition by organizations such as the Japan Academy, the Asahi Shimbun through the Asahi Prize, and scientific societies including the European Molecular Biology Organization. Culminating his accolades, he was awarded the Nobel Prize in Physiology or Medicine for discoveries of mechanisms for autophagy, joining laureates affiliated with institutions like Karolinska Institute and the Royal Swedish Academy of Sciences. He received honorary degrees and prizes from universities including University of Oxford, University of Cambridge, ETH Zurich, and research foundations connected to Wellcome Trust and Gordon and Betty Moore Foundation.
In later decades Ohsumi continued to mentor students and collaborate with laboratories at the Tokyo Institute of Technology and international centers including European Research Council-funded groups and consortia involving National Institute for Health Research partners. His conceptual framework for autophagy influenced clinical and translational research into neurodegenerative disorders studied at Mayo Clinic and Charité – Universitätsmedizin Berlin, cancer biology programs at Memorial Sloan Kettering Cancer Center and Dana–Farber Cancer Institute, and metabolic research at Lund University. Ohsumi's legacy endures through the Atg nomenclature adopted across databases curated by organizations like UniProt and Gene Ontology Consortium and through annual symposia hosted at venues including Cold Spring Harbor Laboratory and the Royal Society. His experimental paradigms have been integrated into curricula at universities such as McGill University and University of Melbourne, ensuring continued impact on cell biology research worldwide.
Category:Japanese biologists Category:Nobel laureates in Physiology or Medicine Category:University of Tokyo alumni